Systematic evaluation was conducted to determine CYP NPs and PTX NPs’ performance in overcoming drug-resistant breast cancer and to understand the mechanism of how the two agents work at the cellular, multicellular spheroid, and animal levels. The gene discussed is PPIG; the disease is breast carcinoma.